TheraRadar
Clinical-Stage Companies / TBF Genie Tissulaire

TBF Genie Tissulaire

Pre-Approval PRO BETA
20
Total Trials
4
Phase 3
13
Phase 2
4
Recruiting
189
Score

Pipeline by Phase

Phase 3
4
Phase 2
13
Phase 1
5

Therapeutic Focus

Osteoarthritis Hand Corneal Ulcer Trapeziometacarpal Osteoarthritis Stress Urinary Incontinence in Women Progressive Keratoconus

Clinical Trials (20)

NCT06450470 Phase 3 RECRUITING

Use of a Freeze-dried Amniotic Membrane Post Crosslinking in Subjects With Progressive Keratoconus

Started: 11/25/2024

NCT06678984 Phase 3 NOT YET RECRUITING

Treated Umbilical Vein Allograft (UVT) Versus Autologous Fascial Pubovaginal Sling in the Treatment of Female Stress Urinary Incontinence

Started: 10/1/2025

NCT05247658 Phase 3 TERMINATED

Use of a Disk of Amniotic Membrane (Visio-AMTRIX) in Postoperative Care After PKR

Started: 1/25/2022

NCT00945399 Phase 3 TERMINATED

Comparison of Microfracture Treatment and CARTIPATCH® Chondrocyte Graft Treatment in Femoral Condyle Lesions

Started: 10/1/2008

NCT06038331 Phase 2 RECRUITING

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of STT Osteoarthritis

Started: 5/28/2024

NCT06034262 Phase 2 RECRUITING

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of PIP Joint Osteoarthritis

Started: 10/7/2024

NCT06723782 Phase 2 RECRUITING

Surgical Release of Hand Tendons with Wrapping of the Released Tendon Using an Amniotic Membrane

Started: 2/15/2024

NCT07435571 Phase 2 NOT YET RECRUITING

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of Trapeziometacarpal Osteoarthritis

Started: 3/1/2026

NCT05250583 Phase 2 TERMINATED

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis

Started: 6/29/2020

NCT05199155 Phase 2 TERMINATED

Use of a Nerve Regeneration Conduit (NerVFIX®) in the Treatment of Nerve Section of the Wrist

Started: 12/8/2020

NCT05250726 Phase 2 COMPLETED

Use of a Treated, Devitalized and Sterile Meniscus Segment (MENISC-T) in the Treatment of Scaphotrapeziotrapezoid Osteoarthritis

Started: 1/1/2021

NCT05302609 Phase 2 TERMINATED

Evaluation of SclerFIX Graft in Scleral Thinning After Exeresis of Tumors of the Ocular Surface

Started: 7/4/2022

NCT05207189 Phase 2 COMPLETED

Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Complications

Started: 11/8/2021

NCT05191628 Phase 2 TERMINATED

Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole

Started: 6/10/2020

NCT05172349 Phase 2 WITHDRAWN

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers

Started: 4/1/2022

NCT05638139 Phase 1 COMPLETED

Treatment of Ano-perineal Fistulas Resistant to Surgical Treatment with a Gel and Plug of Wharton's Jelly

Started: 6/27/2023

NCT05200000 Phase 1 COMPLETED

Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis

Started: 1/8/2020

NCT05236049 Phase 1 COMPLETED

Use of an Allograft Set-up (SclerFIX) as Replacement of Sclera Graft for Support of Enucleation Implant

Started: 7/1/2019

NCT02430558 Phase 1 TERMINATED

Second Line Treatment of Knee Osteochondral Lesion With Treated Osteochondral Graft

Started: 4/5/2016

NCT02736318 Phase 1 TERMINATED

OD-PHOENIX in Talus Osteochondral Lesion

Started: 1/27/2017

Drug Candidates

SclerFIX-IP AMTRIX-D LV-Visio-AMTRIX SygeLIX-F + SygeLIX-G NerVFIX MENISC-T SclerFIX UVT SygeLIX-Coll-T Visio-AMTRIX
Activity Status: Active
Last Trial Started: 3/1/2026
Last Trial Ended: 8/13/2024
Trials (12 months): 2
Completed Trials: 5
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.